Confidence Intervals
Showing 1 - 25 of 8,364
COVID-19 Novel Molecular Point of Care Diagnostics Evaluation
Completed
- COVID-19 Respiratory Infection
-
Geneva, Switzerland
- +2 more
Sep 25, 2023
Heart Failure Trial in Ibadan
Recruiting
- Heart Failure
-
Ibadan, Oyo, NigeriaUniversity College Hospital Ibadan
Jun 29, 2023
Urdu Version of Tinetti Falls Efficacy Scale
Completed
- Stroke
-
Lahore, Punjab, PakistanUniversity of Lahore Teaching Hospital
Sep 12, 2023
Inpatient COVID-19 Treatments
Active, not recruiting
- COVID-19
- Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)
-
New York, New YorkAetion, Inc.
Jan 12, 2023
Next Generation LAM Assays and Molecular Diagnostics for
Not yet recruiting
- Tuberculosis
- (no location specified)
Aug 24, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Biospecimen Collection
- +8 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 27, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Atezolizumab
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2023
Novel Thermal Imaging Technique for Breast Screening
Recruiting
- Breast Cancer
- Thermalytix
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Dec 14, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma
Not yet recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +3 more
- Accelerated Partial Breast Irradiation
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 18, 2023
Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Amivantamab
- +3 more
- (no location specified)
Oct 30, 2023
Non-Alcoholic Fatty Liver Disease Trial in Seoul (GODEX, Placebo)
Enrolling by invitation
- Non-Alcoholic Fatty Liver Disease
- GODEX
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 30, 2023
Educational Activities Trial in Montreal (Intervention)
Recruiting
- Educational Activities
- Intervention
-
Montreal, Quebec, CanadaInstitut de Recherches Cliniques de Montréal
Sep 2, 2022
Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,
Not yet recruiting
- Recurrent Glioblastoma, IDH-Wildtype
- +2 more
- Biospecimen Collection
- +2 more
- (no location specified)
May 13, 2023
Minimal Residual Disease Using Multi-omics Approach
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
-
Shanghai, ChinaDepartment of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Nov 29, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Philadelphia (Magnetic Resonance Imaging, Computed
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Magnetic Resonance Imaging
- +4 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023
Cancer, Immune-related Adverse Event, Cardiac Abnormalities, Variable Trial in Belgium (Cardiology consultation, Chest Computed
Recruiting
- Cancer
- +6 more
- Cardiology consultation
- +4 more
-
Deinze, East-Flanders, Belgium
- +3 more
Jan 26, 2023
Nasal Polyps, Asthma, COPD Trial in Oulu (Sensor analyzing software (own development), Body plethysmograph)
Recruiting
- Nasal Polyps
- +3 more
- Sensor analyzing software (own development)
- Body plethysmograph
-
Oulu, FinlandOulu University Hospital
May 23, 2023
Meningeal Tumors, Leptomeningeal Disease Trial in Tübingen (No intervention)
Not yet recruiting
- Meningeal Neoplasms
- Leptomeningeal Disease
- No intervention
-
Tübingen, GermanyUniversity Hospital Tübingen, Neurooncology
Nov 16, 2023
ADHD Trial (DBT for ADHD)
Not yet recruiting
- ADHD
- DBT for ADHD
- (no location specified)
Apr 21, 2023
Epithelial Ovarian Cancer, Anemia, Iron Deficiency Anemia Trial in Madison (Iron Sucrose)
Terminated
- Epithelial Ovarian Cancer
- +2 more
- Iron Sucrose
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jan 3, 2023
Nervous System Tumor Trial (Administration of Indocyanine Green (ICG) and Visualization of Tumor)
Not yet recruiting
- Nervous System Tumor
- Administration of Indocyanine Green (ICG) and Visualization of Tumor
- (no location specified)
Feb 17, 2023
Autoimmune Disorders Trial in United States (Daratumumab)
Not yet recruiting
- Autoimmune Disorders
- Daratumumab
-
Baltimore, Maryland
- +7 more
Jan 4, 2023
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +5 more
- (no location specified)
Sep 7, 2023
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Baltimore, Buffalo (Gemtuzumab Ozogamicin,
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Gemtuzumab Ozogamicin
- +4 more
-
Baltimore, Maryland
- +1 more
Dec 13, 2022
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +5 more
- Biospecimen Collection
- +4 more
- (no location specified)
Oct 28, 2022